Atorvastatin improving renal ischemia reperfusion injury via direct inhibition of active caspase-3 in rats

Experimental Biology and Medicine

Volumn 236, Issue 6, 2011, Pages 755-763

  Haylor, John L ^a   Harris, Kevin P G ^b   Nicholson, Michael L ^b   Waller, Helen L ^b   Huang, Qiang ^b   Yang, Bin ^b,c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c University of Nantong   (China)

Author keywords

Apoptosis; Atorvastatin; Caspase 3; Inflammation; Ischemia and ischemia reperfusion injury

Indexed keywords

ATORVASTATIN; CASPASE 3; CASPASE 3 INHIBITOR; CHOLESTEROL; CREATININE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTERY CLAMP; ARTICLE; CELL DEATH; CELL INFILTRATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; IN VITRO STUDY; INTERSTITIAL NEPHRITIS; KIDNEY ISCHEMIA; KIDNEY TUBULE NECROSIS; MALE; MONOCYTE; NEPHRECTOMY; NITROSYLATION; NONHUMAN; PROTEIN CARBONYLATION; PROTEIN CLEAVAGE; RAT; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; CASPASE 3; CREATININE; ENZYME INHIBITORS; HEPTANOIC ACIDS; KIDNEY TUBULES; METABOLIC CLEARANCE RATE; PROTECTIVE AGENTS; PYRROLES; RATS; REPERFUSION INJURY;

RATTUS;

EID: 79958844511     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.010350     Document Type: Article

References (37)

1. Campese VM, Nadim MK, Epstein M. Are 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors renoprotective? J Am Soc Nephrol 2005;16:S11-S17
2. Efthymiou CA, Mocanu MM, Yellon DM. Atorvastatin and myocardial reperfusion injury: new pleiotropic effect implicating multiple prosurvival signaling. J Cardiovasc Pharmacol 2005;45:247-252
3. Blanco-Colio LM, Tunon J, Martin-Ventura JL, Egido J. Anti-inflammatory and immunomodulatory effects of statins. Kidney Int 2003;63:12-23
4. Gottmann U, Brinkkoetter PT, Hoeger S, Gutermann K, Coutinho ZM, Ruf T, Hui S, Liu Z, Schnuelle P, van der Woude FJ, Braun C, YardAtorvastatin donor pretreatment prevents ischemia/reperfusion injury in renal transplantation in rats: possible role for aldose-reductase inhibition. Transplantation 2007;84:755-762
5. Khwaja A, O'Connolly J, Hendry BM. Prenylation inhibitors in renal disease [see comment]. Lancet 2000;355:741-744
6. Schouten O, Kok NF, Boersma E, Bax JJ, Feringa HH, Vidakovic R, Statius van Eps RG, van Sambeek MR, Poldermans D. Effects of statins on renal function after aortic cross clamping during major vascular surgery. Am J Cardiol 2006;97:1383-1385
7. Nesic Z, Todorovic Z, Stojanovic R, Basta-Jovanovic G, Radojevic-Skodric S, Velickovic R, Chatterjee PK, Thiemermann C, Prostran M. Single-dose intravenous simvastatin treatment attenuates renal injury in an experimental model of ischemia-reperfusion in the rat. J Pharmacol Sci 2006;102:413-417
8. Gueler F, Rong S, Park JK, Fiebeler A, Menne J, Elger M, Mueller DN, Hampich F, Dechend R, Kunter U, Luft FC, Haller H. Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. J Am Soc Nephrol 2002;13:2288-2298
9. Wang CY, Liu PY, Liao JK. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends Mol Med 2008;14:37-44
10. Nobes CD, Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995;81:53-62
11. Oda H, Keane WF. Recent advances in statins and the kidney. Kidney Int Suppl 1999;71:S2-S5
12. Buemi M, Senatore M, Corica F, Aloisi C, Romeo A, Cavallaro E, Floccari F, Tramontana D, Frisina N. Statins and progressive renal disease. Med Res Rev 2002;22:76-84
13. Yoshimura A, Inui K, Nemoto T, Uda S, Sugenoya Y, Watanabe S, Yokota N, Taira T, Iwasaki S, Ideura T. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis. J Am Soc Nephrol 1998;9:2027-2039
14. Heusinger-Ribeiro J, Fischer B, Goppelt-Struebe M. Differential effects of simvastatin on mesangial cells. Kidney Int 2004;66:187-195
15. Pirhonen J, Sareneva T, Julkunen I, Matikainen S. Virus infection induces proteolytic processing of IL-18 in human macrophages via caspase-1 and caspase-3 activation. Eur J Immunol 2001;31:726-733
16. Yang B, Jain S, Ashra SY, Furness PN, Nicholson ML. Apoptosis and caspase-3 in long-term renal ischemia/reperfusion injury in rats and divergent effects of immunosuppressants. Transplantation 2006;81:1442-1450
17. Weight SC, Furness PN, Nicholson ML. New model of renal warm ischaemia-reperfusion injury for comparative functional, morphological and pathophysiological studies. Br J Surg 1998;85:1669-1673
18. Bell RM, Yellon DM. Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway. J Am Coll Cardiol 2003;41:508-515
19. Shum YY, Huang N, Walter G, Black A, Sekerke C, Chang T, Whitfield LR. Development, validation, and interlaboratory comparison of an HMG-CoA reductase inhibition assay for quantitation of atorvastatin in plasma matrices. Ther Drug Monit 1998;20:41-49
20. Harris KP, Wheeler DC, Chong CC, Atorvastatin in CAPD Study I, Continuous ambulatory peritoneal d. A placebo-controlled trial examining atorvastatin in dyslipidemic patients undergoing CAPD. Kidney Int 2002;61:1469-1474
21. Yang B, Jain S, Pawluczyk IZ, Imtiaz S, Bowley L, Ashra SY, Nicholson ML. Inflammation and caspase activation in long-term renal ischemia/ reperfusion injury and immunosuppression in rats. Kidney Int 2005;68:2050-2067
22. Waller HL, Harper SJ, Hosgood SA, Bagul A, Yang B, Kay MD, Kaushik M, Nicholson ML. Biomarkers of oxidative damage to predict ischaemia-reperfusion injury in an isolated organ perfusion model of the transplanted kidney. Free Radic Res 2006;40:1218-1225
23. Chiang CK, Yang SY, Peng YS, Hsu SP, Pai MF, Huang JW, Hung KY, Wu KD. Atorvastatin increases erythropoietin-stimulating agent hyporesponsiveness in maintenance hemodialysis patients: role of anti-inflammation effects. Am J Nephrol 2009;29:392-397
24. Crisby M. Modulation of the inflammatory process by statins. Timely Top Med Cardiovasc Dis 2005;9:E3
25. Miwa K, Asano M, Horai R, Iwakura Y, Nagata S, Suda T. Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer fas ligand. Nat Med 1998;4:1287-1292
26. Faouzi S, Burckhardt BE, Hanson JC, Campe CB, Schrum LW, Rippe RA, Maher JJ. Anti-fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway. J Biol Chem 2001;276:49077-49082
27. Erl W. Atorvastatin-induced downregulation of survivin and vascular smooth muscle cell apoptosis: a causal relationship in restenosis? [comment]. Cardiovasc Drugs Ther 2007;21:141-144
28. Mizuguchi Y, Miyajima A, Kosaka T, Asano T, Asano T, Hayakawa M. Atorvastatin ameliorates renal tissue damage in unilateral ureteral obstruction. J Urol 2004;172:2456-2459
29. Chatterjee PK, Todorovic Z, Sivarajah A, Mota-Filipe H, Brown PA, Stewart KN, Cuzzocrea S, Thiemermann C. Differential effects of caspase inhibitors on the renal dysfunction and injury caused by ischemia-reperfusion of the rat kidney. Eur J Pharmacol 2004;503:173-183
30. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312-1316
31. Voss OH, Batra S, Kolattukudy SJ, Gonzalez-Mejia ME, Smith JB, Doseff AI. Binding of caspase-3 prodomain to heat shock protein 27 regulates monocyte apoptosis by inhibiting caspase-3 proteolytic activation. J Biol Chem 2007;282:25088-25099
32. Sabbatini M, Pisani A, Uccello F, Serio V, Seru R, Paterno R, Cianciaruso B, Fuiano G, Andreucci M. Atorvastatin improves the course of ischemic acute renal failure in aging rats. J Am Soc Nephrol 2004;15:901-909
33. Foster MW, Stamler JS. New insights into protein S-nitrosylation. mitochondria as a model system. J Biol Chem 2004;279:25891-25897
34. Melino G, Bernassola F, Knight RA, Corasaniti MT, Nistico G, Finazzi-Agro A. S-nitrosylation regulates apoptosis. Nature 1997;388:432-433
35. Mattana J, Kochlatyi S, Gibbons N. Metal-catalyzed oxidation of extracellular matrix proteins promotes human mesangial cell apoptosis and is associated with enhanced expression of bax and caspase activation. Biochem Biophys Res Commun 2002;292:652-658
36. Shi XY, Hou FF, Niu HX, Wang GB, Xie D, Guo ZJ, Zhou ZM, Yang F, Tian JW, Zhang X. Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology 2008;149:1829-1839
37. Erdogan H, Fadillioglu E, Yagmurca M, Ucar M, Irmak MK. Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: protective effects of erdosteine and N-acetylcysteine. Urol Res 2006;34:41-46